About: http://data.cimple.eu/news-article/06e04ba17ffcfab6440b96e2e6cf5c96c0ea3d549f6196ec0430a331

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/06e04ba17ffcfab6440b96e2e6cf5c96c0ea3d549f6196ec0430a331 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Germany is ready to hold talks on a US-backed proposal to waive patents on Covid-19 vaccines, Foreign Minister Heiko Maas said Thursday. "It is a discussion that we're open to," Mass told reporters when asked about US Trade Representative Katherine Tai's announcement Wednesday that Washington now supports calls for a global waiver on patent protections for Covid-19 vaccines while the pandemic rages. Maas said Germany would join the discussion about such a move given the "extraordinary situation" of the global coronavirus outbreak. "If that's a way that can contribute to more people getting vaccines faster then it's a question we have to ask ourselves," he said after talks with his Turkish counterpart, Mevlut Cavusoglu. Maas said Germany was committed to helping to end the pandemic. "That will only be the case when all people are safe around the world and we must do everything in our power to reach that goal as soon as possible," he said. German Health Minister Jens Spahn, however, took a more sceptical line on the US initiative. "We expressly support the goal of the US president -- supplying the world with vaccines is the only way out of the pandemic," Spahn said. However those countries that produce vaccines "must also export them to other countries", Spahn said, pointing to US reticence to allow vaccines to leave its shores. The BioNTech/Pfizer vaccine, which was co-developed by a German company, was the first Covid-19 jab to be approved in the West late last year. European Commission President Ursula von der Leyen had earlier said that Brussels was ready to discuss a vaccine patent waiver. But she also stressed that Europe's priority would be to boost global supplies, and implicitly criticised both the US and the UK for limiting vaccine exports. dlc/hmn/yad
schema:headline	Germany 'open' to discuss waiving Covid-19 jab patents: minister
schema:mentions	President of the European Commission European Commission Heiko Maas Foreign minister Mass in the Catholic Church Jens Spahn Brussels Jab Patent Ursula von der Leyen George Washington Germany Turkey European Union Pandemic Pfizer United Kingdom Vaccine Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Benny Tai Office of the United States Trade Representative Mevlüt Çavuşoğlu Yad
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-06 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software